Armstrong, A. W.; Lebwohl, M.; Warren, R. B.; Sofen, H.; Imafuku, S. .; Ohtsuki, M.; Spelman, L. .; Passeron, T.; Papp, K. A.; Kisa, R. M.; Berger, V.; Vritzali, E.; Hoyt, K.; Colombo, M. J.; Banerjee, S.; Strober, B.; Thaçi, D.; Blauvelt, A. Deucravacitinib in Plaque Psoriasis: 3-Year Safety and Efficacy Results from the Phase 3 POETYK PSO-1 and PSO-2 Trials. J of Skin 2024, 8, s366.